CN108992538A - 一种治疗脱发的中药配方及制备方法 - Google Patents
一种治疗脱发的中药配方及制备方法 Download PDFInfo
- Publication number
- CN108992538A CN108992538A CN201811179699.7A CN201811179699A CN108992538A CN 108992538 A CN108992538 A CN 108992538A CN 201811179699 A CN201811179699 A CN 201811179699A CN 108992538 A CN108992538 A CN 108992538A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- preparation
- alopecia
- cotton yarn
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 230000003779 hair growth Effects 0.000 title claims abstract description 11
- 240000000249 Morus alba Species 0.000 claims abstract description 30
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 30
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 16
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- 229920000742 Cotton Polymers 0.000 claims abstract description 12
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 10
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 9
- 229920001800 Shellac Polymers 0.000 claims abstract description 9
- 239000002304 perfume Substances 0.000 claims abstract description 9
- 235000013874 shellac Nutrition 0.000 claims abstract description 9
- 239000004208 shellac Substances 0.000 claims abstract description 9
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims abstract description 9
- 229940113147 shellac Drugs 0.000 claims abstract description 9
- 235000013599 spices Nutrition 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 235000014101 wine Nutrition 0.000 claims abstract description 4
- 241000208340 Araliaceae Species 0.000 claims abstract 4
- 201000004384 Alopecia Diseases 0.000 abstract description 36
- 231100000360 alopecia Toxicity 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 24
- 239000007788 liquid Substances 0.000 abstract description 10
- 230000003676 hair loss Effects 0.000 abstract description 6
- 208000024963 hair loss Diseases 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 3
- 239000006228 supernatant Substances 0.000 abstract description 3
- 230000001575 pathological effect Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 210000004209 hair Anatomy 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 240000004371 Panax ginseng Species 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 244000241838 Lycium barbarum Species 0.000 description 4
- 235000015459 Lycium barbarum Nutrition 0.000 description 4
- 235000015468 Lycium chinense Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- GDQXJMLXEYSICD-UHFFFAOYSA-N cyclomorusin A Chemical compound C1=CC(C)(C)OC2=CC(O)=C(C(=O)C=3C(C=C(C)C)OC=4C(=CC=C(O)C=4)C=3O3)C3=C21 GDQXJMLXEYSICD-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000001263 FEMA 3042 Substances 0.000 description 3
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 235000017443 Hedysarum boreale Nutrition 0.000 description 3
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 3
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 239000002021 butanolic extract Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 3
- 229940033123 tannic acid Drugs 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- 229930003347 Atropine Natural products 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- DAYVKEVMSODOPS-UHFFFAOYSA-N Cyclomorusin Natural products CC(=CC1Oc2ccccc2C3=C1C(=O)c4c(O)cc5OC(C)(C)C=Cc5c4O3)C DAYVKEVMSODOPS-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003778 catagen phase Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 208000024349 endocrine alopecia Diseases 0.000 description 2
- 150000002240 furans Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000008925 spontaneous activity Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001186 vagus nerve Anatomy 0.000 description 2
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- ZNHVWPKMFKADKW-UHFFFAOYSA-N 12-HETE Chemical compound CCCCCC=CCC(O)C=CC=CCC=CCCCC(O)=O ZNHVWPKMFKADKW-UHFFFAOYSA-N 0.000 description 1
- ZNHVWPKMFKADKW-ZYBDYUKJSA-N 12-HETE Natural products CCCCC\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O ZNHVWPKMFKADKW-ZYBDYUKJSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000000383 Allium odorum Species 0.000 description 1
- 235000018645 Allium odorum Nutrition 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019030 Hair colour changes Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001516928 Kerria lacca Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000721570 Melaphis Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000220221 Rosales Species 0.000 description 1
- 229930182734 Sanggenon Natural products 0.000 description 1
- 241001516602 Schlechtendalia chinensis Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000034557 congenital alopecia Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 244000000013 helminth Species 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗脱发的中药配方及制备方法,通过中药配制的药酒外用涂抹于脱发处,对病理性脱发治疗效果好,无任何毒副作用。其特征在于由以下重量份数的中药原料配制而成:紫草茸9‑30g,五倍子9‑20g,补骨脂6‑30g,红花6‑15g,林下参3‑9g,甘草6‑9g,桑白皮6‑30g,枸杞6‑30g,川芎6‑30g。制备方法是将紫草茸,五倍子,补骨脂,按照上述比例在200°高温下爆香,然后粉碎研磨,再爆香,装入棉纱袋中。再将红花,林下参,甘草,桑白皮,枸杞,川芎按照上述比例粉碎研磨,一起放入棉纱袋中。将装有所有中药配方的棉纱袋放入三年以上的60°粮食酒中浸泡一个月,取上清液体药酒即可。脱发患者每天早中晚分别用5毫升上述药酒涂抹于脱发处,一个月为一个疗程。
Description
技术领域
本发明属于中医中药技术领域,特别涉及一种治疗脱发的中药配方。
背景技术
脱发是指头发脱落的现象。正常脱落的头发都是处于退行期及休止期的毛发,由于进入退行期与新进入生长期的毛发不断处于动态平衡,故能维持正常数量的头发。病理性脱发是指头发异常或过度的脱落,其原因主要有以下几点:1.雄激素性脱发,为常染色体显性遗传,其遗传特征需在雄激素作用下才表现出来。2.神经性脱发,精神压力过大时常常出现脱发增多。在精神压力的作用下,人体立毛肌收缩、头发直立,植物神经或中枢神经机能发生紊乱,毛囊毛乳头发生改变和营养不良,从而导致毛发生长功能抑制,毛发进入休止期而出现脱发。3.内分泌脱发,毛发生长受多种内分泌激素的影响,所以当发生内分泌异常时多引起脱发疾病,如产后、更年期脱发。4.营养性脱发,毛发是身体状况的外在表现,机体营养不良和新陈代谢异常可引起发质和发色的改变,严重营养不良甚至导致弥漫性脱发。5.物理性脱发,常见的引起脱发的物理性因素包括机械性刺激和接触放射性物质。6.化学性脱发,化学因素可以导致毛发颜色改变甚至脱发。7.感染性脱发,各种病原体的感染是毛发疾病中一类重要因素,主要包括细菌、病毒、真菌、螺旋体、寄生虫等感染。8.症状性脱发,某些系统性或局部疾病都可伴发脱发。9.先天性脱发,发育缺陷所引起的头发完全缺失或稀疏,患者常见头发稀疏细小,或出生时头发正常,不久就脱落不再生,可分为孤立缺陷和其他畸形。10.季节性脱发,一般夏季容易脱发,因为夏天温度高毛孔扩张导致脱发,秋冬之际不易脱发,因为这时期温度下降毛孔闭合。
发明内容
本发明提供一种治疗脱发的中药配方及制备方法,通过中药配制的药酒外用涂抹于脱发处,科学合理调节内分泌,对病理性脱发治疗效果好,无任何毒副作用。
本发明治疗脱发的中药配方,其特征在于由以下重量份数的中药原料配制而成 :紫草茸9-30g,五倍子9-20g,补骨脂6-30g,红花6-15g,林下参3-9g,甘草6-9g,,桑白皮6-30g,枸杞6-30g,川芎6-30g。
本发明所述中药配方药理详解:
紫草茸,中药名。为胶蚧科动物紫胶虫在树枝上所分泌的干燥胶质。具有清热,凉血,解毒之功效。用于麻疹,斑疹不透,月经过多,崩漏,疮疡,湿疹,外用可治疮疡不敛,肿毒。本品呈半圆柱状,长短宽狭不一。紫褐色或紫红色,表面凹凸不平,有皱纹及小虫眼孔隙,附着于树枝处呈凹沟状,边缘钝圆。质硬而脆,可折断。断面有平行排列的长圆形或圆形虫窝,内有长卵形或圆形虫尸,褐色或暗红色。气微臭,味淡。遇热则软化而发粘。
五倍子,又名百虫仓、百药煎、棓子,为同翅目蚜虫科的角倍蚜或倍蛋蚜雌虫寄生于漆树科植物“盐肤木”及其同属其他植物的嫩叶或叶柄,刺伤而生成一种囊状聚生物虫瘿,经烘焙干燥后所得。此外,五倍子还是一种药材,可以治疗多种疾病。五倍子含有鞣酸,有沉淀蛋白质的作用,皮肤溃疡面、黏膜与其接触后,组织蛋白质即被凝固,形成一层保护膜,起收敛作用,同时小血管也被压迫收缩,血液凝结而呈止血作用。腺细胞的蛋白质被凝固引起分泌抑制,使黏膜干燥,神经末梢蛋白质的沉淀,可呈微弱的局部麻醉现象。五倍子中所含鞣酸对正常小肠运动无甚影响,但由于其收敛作用而减轻肠道炎症,故可制止腹泻。抗菌作用,体外试验表明:五倍子煎剂对金黄色葡萄球菌、乙型溶血性链球菌、肺炎球菌、绿脓杆菌、痢疾杆菌、炭疽杆菌、白喉杆菌、大肠杆菌、伤寒和副伤寒杆菌等均有明显的抑菌和杀菌作用。经用乙醚提出其鞣酸后的五倍子液仍有抑菌作用。但五倍子心部的煎剂无抗菌作用。
补骨脂,又名:破故纸,婆固脂,胡韭子。属蔷薇目,豆科一年生直立草本,高60~150cm。叶为单叶,长7~8mm;叶柄长2~4.5cm,叶宽卵形,花序腋生,有花10~30朵,花冠黄色或蓝色,花瓣明显具瓣柄,旗瓣倒卵形,荚果卵形,花、果期7~10月。果实入药,有补肾壮阳、补脾健胃之功能,并可治牛皮癣等皮肤病。药性:苦、辛、温。归肾、脾经。主治1.用于治疗肾虚阳痿,腰膝酸软冷痛,肾虚遗精,遗尿,尿频等。2用于治疗脾肾阳虚引起的五更泄泻。3用于治疗肾不纳气之虚寒喘咳。
红花,别名:红蓝花 、刺红花,菊科、红花属植物,干燥的管状花,橙红色,花管狭细,先端5裂,裂片狭线形,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。活血通经,散瘀止痛,有助于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛疗效。有活血化瘀,散湿去肿的功效。
林下参,别称籽海山参,由人工播种到乔木、灌木、杂草组成的针阔叶混交的森林中,无人工干预,纯自然生长。让高中低三层树种形成的自然屏障,既能遮挡强光,又能在散射光中进行光合作用。1.人参对中枢神经系统具有兴奋作用,能减少疲劳感。2.人参对心肌及血管有直接作用,一般在小剂量时兴奋,大剂量时抑制,亦有抗过敏性休克及强心的作用。3.加强机体对有害因素的抵抗力,在大量失血或窒息而处于垂危状态时,服用人参,可使降至很低水平的血压稳固回升。促进损伤的愈合。有抗维生素B1、B2缺乏症的作用。4.对因肾上腺素引起的高血糖动物有降低血糖的作用;对糖尿病患者除能自觉改善症状外,还有轻微的降血糖作用,并与胰岛素有协同作用。5.能促进动物的性腺功能,小白鼠吃小量人参,能产生举尾现象。6.对家兔也能增加体重,使血浆白蛋白的比值上升。7.刺激造血器官,有改善贫血的作用。人参自古以来拥有“百草之王”的美誉,富含野生人参的珍贵营养成分,大补元气、回阳散逆、滋阴、益血、生津、强心。
甘草,别名:国老、甜草、乌拉尔甘草、甜根子。豆科、甘草属多年生草本,根与根状茎粗壮,是一种补益中草药。对人体很好的一种药,药用部位是根及根茎,药材性状根呈圆柱形,长25~100厘米,直径0.6~3.5厘米。外皮松紧不一,表面红棕色或灰棕色。根茎呈圆柱形,表面有芽痕,断面中部有髓。气微,味甜而特殊。功能主治清热解毒、祛痰止咳、脘腹等。喜阴暗潮湿,日照长气温低的干燥气候。甘草多生长在干旱、半干旱的荒漠草原、沙漠边缘和黄土丘陵地带。根和根状茎供药用。其功效有:1.用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力等。前者,常与桂枝配伍,如桂枝甘草汤、炙甘草汤。后者,常与党参、白术等同用,如四君子汤、理中丸等。2.用于痈疽疮疡、咽喉肿痛等。可单用,内服或外敷,或配伍应用。痈疽疮疡,常与金银花、连翘等同用,共奏清热解毒之功,如仙方活命饮。咽喉肿痛,常与桔梗同用,如桔梗汤。若农药、食物中毒,常配绿豆或与防风水煎服。3.用于气喘咳嗽。可单用,亦可配伍其他药物应用。如治湿痰咳嗽的二陈汤;治寒痰咳喘的苓甘五味姜辛汤;治燥痰咳嗽的桑杏汤;治热毒而致肺痈咳唾腥臭脓痰的桔梗汤;治咳唾涎沫的甘草干姜汤等。另风热咳嗽、风寒咳嗽、热痰咳嗽亦常配伍应用。4.用于胃痛、腹痛及腓肠肌挛急疼痛等,常与芍药同用,能显著增强治挛急疼痛的疗效,如芍药甘草汤。5.用于调和某些药物的烈性。如调味承气汤用本品缓和大黄、芒硝的泻下作用及其对胃肠道的刺激。另外,在许多处方中也常用本品调和诸药。7 .甘草有类似肾上腺皮质激素样作用。对组胺引起的胃酸分泌过多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用。8. 甘草黄酮、甘草浸膏及甘草次酸均有明显的镇咳作用;祛痰作用也较显著,其作用强度为甘草酸>甘草黄酮>甘草浸膏。9. 甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜。甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用。10. 甘草常用来治疗随更年期而来的症状.因为甘草里含有甘草素,是一种类似激素的化合物,它有助于平衡女性体内的激素含量。11.甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
桑白皮为桑科植物桑的干燥根皮。别名桑根白皮、桑根皮、桑皮、白桑皮。主产于安徽、河南、浙江、江苏、湖南等地。秋末落叶时至次春发芽前采挖根部,刮去黄棕色粗皮,纵向剖开,剥取根皮,晒干。药理作用:1. 降压,桑白皮的醇提取液5~6mg/kg,对麻醉兔、犬十二指肠给药可使动物血压明显而持久的下降。而对实验性肾性高血压的动物20g/kg口服,亦能产生明显的降压作用。切断两侧迷走神经或于第5~6颈椎部位切断脊髓,其降压作用不变。桑白皮用乙醚、热水或温甲醇的提取液,对兔皮下注射1g(生药)/kg时,可使血压下降2~3.3kPa。从桑白皮中提得一种物质[熔点(分解)为144℃],给家兔静注10mg/kg,血压立即显著下降,切断颈迷走神经或颈椎,此作用仍存在,故推断提取物中可能是乙酰胆碱样物质。桑白皮提取物能抑制离体蛙心、兴奋兔离体肠管,而降低血压作用可被阿托品对抗。提示此种降压抑制,可能是抑制了血管运动中枢而出现的,降压同时对肾血流量似有增加。从桑白皮中分离出的桑根酮静注家兔,即能显著降压,环桑皮素、桑皮呋喃C等都有降压作用。2.利尿作用,桑白皮煎剂2g/kg,给家兔口服或桑白皮水提取液及正丁醇提取物300~500mg/kg,给大鼠口服或腹腔注射,均有显著的利尿作用。3.镇静镇痛作用,桑白皮的石油醚、乙醚、乙酸乙酯等脂溶性溶媒的提取物给小鼠静注,能减少小鼠的自发活动,并有抗惊厥的作用。桑白皮水或正丁醇提取物50mg/kg以上腹腔注射小鼠,可使动物自发活动减少,触觉及痛觉反应降低,瞳孔散大,并能轻度抑制小鼠电休克的发生。4.抗炎作用,桑白皮水提取物给大鼠口服或注射对角叉菜胶及葡聚糖所引起的脚肿胀有抑制作用。5.抗菌作用,桑白皮煎剂对金黄色葡萄球菌有较强的抑制作用;对伤寒杆菌及福氏痢疾杆菌也有轻度的抑制作用。桑皮呋喃A对金黄色葡萄球菌、分歧杆菌均有较强的抑菌活性。环桑皮素也有抗真菌作用。6.抑制血小板聚集,桑白皮中所含酸性物质,可影响血小板内的环氧合酶,从而抑制了 TBX2的生物合成,或抑制12-HETE的生成,通过改变花生四烯酸的代谢,影响血小板的聚集。7.降糖作用,桑白皮中分离并证实了降血糖成分Moranoline(脱二氧亚胺基葡萄醇)和MoranA降糖物质,经过试验,已经证实了MoranA对四氧嘧啶诱发的高血糖小鼠(血糖250~450mg/dL)有剂量依赖的降糖效果。8. 其他作用,桑白皮热水提取物体外试验,对人子宫颈癌JTC-26株的抑制率为70%左右,具有诱生干扰素作用。桑白皮能兴奋离体兔子宫,轻度促进兔耳下腺的分泌。并能抑制磷酸二酯酶。有导泻作用。桑白皮水提取物对豚鼠有轻度镇咳作用,正丁醇提取物也有镇咳作用,还具有一定降温作用。以桑白皮为主药的解热清脑糖浆也有较好的解热、祛痰止咳作用。
枸杞,主要成份:含甜菜碱,阿托品,天仙子胺,枸杞多糖。枸杞多糖是一种水溶性多糖,是枸杞中最主要的活性成分,相对分子质量为68-200。其中又以枸杞多糖的免疫调节和抗肿瘤作用的研究最多。现已有很多研究表明枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。甜菜碱:是枸杞果、叶、柄中主要的生物碱之一。枸杞对脂质代谢或抗脂肪肝的作用主要是由于所含的甜菜碱引起的,它在体内起甲基供应体的作用。关于枸杞甜菜碱的研究仅限于国内在含量的测定、提取工艺和对枸杞植物的生理作用(增强耐盐性)研究方面,关于枸杞甜菜碱的药理药效研究很少。枸杞色素:枸杞色素是存在于枸杞浆果中的各类呈色物质,是枸杞籽的重要生理活性成分。主要包括-胡萝卜素、叶黄素和其他有色物质。枸杞所含有的类胡萝卜素则具有非常重要的药用价值。很多研究已经证明枸杞籽色素具有提高人体免疫功能、预防和抑制肿瘤及预防动脉粥样硬化等作用。胡萝卜素是枸杞色素的主要活性成分,具有抗氧化和作为维生素A的合成前体等重要的生理功能。药理作用:对免疫功能有影响作用。性味:枸杞子:甘,平。枸杞叶:苦、甘;性凉。功能:枸杞子:养肝,滋肾,润肺。枸杞叶:补虚益精,清热明目。
川芎,栽培植物,主产于四川,在云南、贵州、广西等地,生长于温和的气候环境。是一种中药植物,常用于活血行气,祛风止痛,川芎辛温香燥,走而不守,既能行散,上行可达巅顶;又入血分,下行可达血海。活血祛瘀作用广泛,适宜瘀血阻滞各种病症;祛风止痛,效用甚佳,可治头风头痛、风湿痹痛等症。昔人谓川芎为血中之气药,殆言其寓辛散、解郁、通达、止痛等功能。
制备方法是将紫草茸,五倍子,补骨脂,按照上述比例在200°高温下爆香,然后粉碎研磨,再爆香,装入棉纱袋中。再将红花,林下参,甘草,桑白皮,枸杞,川芎按照上述比例粉碎研磨,一起放入棉纱袋中。将装有所有中药配方的棉纱袋放入三年以上的60°粮食酒中浸泡一个月,取上清液体药酒即可。
脱发患者每天早中晚分别用5毫升上述药酒涂抹于脱发处,一个月为一个疗程。
治疗结果 :治疗脱发 100 例,一个月疗程痊愈 80 例,好转 15例,无效 5 例,治愈率 80%,显效率15%,无效率 5%。
附几例病例作进一步说明 :
病例 1 :张某,女,45岁,更年期脱发,每天早中晚分别用5毫升上述药酒涂抹于脱发处,15天开始好转,一个月后长出新发,随访1年无复发。
病例 2 :陈某某,男,38 岁,神经性脱发,每天早中晚分别用5毫升上述药酒涂抹于脱发处,20天开始好转,一个月后长出新发,随访1年无复发。
病例 3 :朱某,女,36 岁,内分泌性脱发,每天早中晚分别用5毫升上述药酒涂抹于脱发处,25天开始好转,一个月后长出新发,随访1年无复发。
具体实施方式
本发明治疗脱发的中药配方,其特征在于由以下重量份数的中药原料配制而成 :紫草茸9-30g,五倍子9-20g,补骨脂6-30g,红花6-15g,林下参3-9g,甘草6-9g,,桑白皮6-30g,枸杞6-30g,川芎6-30g。
制备方法是将紫草茸,五倍子,补骨脂,按照上述比例在200°高温下爆香,然后粉碎研磨,再爆香,装入棉纱袋中。再将红花,林下参,甘草,桑白皮,枸杞,川芎按照上述比例粉碎研磨,一起放入棉纱袋中。将装有所有中药配方的棉纱袋放入三年以上的60°粮食酒中浸泡一个月,取上清液体药酒即可。
脱发患者每天早中晚分别用5毫升上述药酒涂抹于脱发处,一个月为一个疗程。
Claims (1)
1.一种治疗脱发的中药配方及制备方法,其特征在于由以下重量份数的中药原料配制而成 :紫草茸9-30g,五倍子9-20g,补骨脂6-30g,红花6-15g,林下参3-9g,甘草6-9g,,桑白皮6-30g,枸杞6-30g,川芎6-30g,制备方法是将紫草茸,五倍子,补骨脂,按照上述比例在200°高温下爆香,然后粉碎研磨,再爆香,装入棉纱袋中,再将红花,林下参,甘草,桑白皮,枸杞,川芎按照上述比例粉碎研磨,一起放入棉纱袋中,将装有所有中药配方的棉纱袋放入三年以上的60°粮食酒中浸泡一个月。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811179699.7A CN108992538A (zh) | 2018-10-10 | 2018-10-10 | 一种治疗脱发的中药配方及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811179699.7A CN108992538A (zh) | 2018-10-10 | 2018-10-10 | 一种治疗脱发的中药配方及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108992538A true CN108992538A (zh) | 2018-12-14 |
Family
ID=64589392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811179699.7A Pending CN108992538A (zh) | 2018-10-10 | 2018-10-10 | 一种治疗脱发的中药配方及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108992538A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114948932A (zh) * | 2022-06-13 | 2022-08-30 | 浩溪(海南)生物科技有限公司 | 包含桑根酮的组合物在制备通过作用于毛囊组织防治脱发的产品中的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101884775A (zh) * | 2009-05-13 | 2010-11-17 | 惠振明 | 促使毛发再生的中药擦剂 |
-
2018
- 2018-10-10 CN CN201811179699.7A patent/CN108992538A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101884775A (zh) * | 2009-05-13 | 2010-11-17 | 惠振明 | 促使毛发再生的中药擦剂 |
Non-Patent Citations (3)
Title |
---|
王万春: "《脱发效验秘方》", 31 January 2014, 中国医药科技出版社 * |
精彩亿佰芬: "中草药能养发生发的有哪些?不起眼路边的野草也有大用途", 《HTTPS://DY.163.COM/ARTICLE/D04R1P2A0514BN6H.HTML》 * |
韩乐等: "甘草酸二铵对人毛囊生长作用及对Wnt/β连环蛋白信号通路的影响", 《中华皮肤科杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114948932A (zh) * | 2022-06-13 | 2022-08-30 | 浩溪(海南)生物科技有限公司 | 包含桑根酮的组合物在制备通过作用于毛囊组织防治脱发的产品中的用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100893106B1 (ko) | 발모용 조성물 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN105343625A (zh) | 一种排毒除湿利胆的蒲公英口服液及其制备方法 | |
KR101128564B1 (ko) | 생숙조화(生熟調和) 발효식초로 산도를 조절한 지초비누의 제조방법 | |
CN105496917A (zh) | 一种积雪草抗皱面霜及其制备方法 | |
CN106107100A (zh) | 羊体增膘用饲料添加剂及其制备方法 | |
CN108992538A (zh) | 一种治疗脱发的中药配方及制备方法 | |
CN102349950A (zh) | 一种食品、保健品或药物组合物及其制备方法和用途 | |
KR101206009B1 (ko) | 탈모 예방 및 발모 촉진용 헤어토닉 조성물의 제조방법 | |
CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
CN103860977B (zh) | 一种治疗皮炎的药物组合物 | |
CN102755519B (zh) | 葛根葛花抗口腔溃疡颗粒及其制备方法 | |
CN113018398A (zh) | 一种抗疲劳保健品及其制备方法 | |
KR101048939B1 (ko) | 발모촉진용 제품의 제조방법 | |
CN105169278A (zh) | 一种保肝利胆的蒲公英口服液及其制备方法 | |
CN104689283A (zh) | 一种治疗脾虚湿蕴型黄褐斑的药物及其制备方法 | |
CN105560984B (zh) | 一种益气健脾的中药组合物 | |
CN109528865A (zh) | 一种用于治疗中老年眼科疾病的中药制剂及其制备方法 | |
CN108354879A (zh) | 一种祛痘防感染的面霜及其制备方法 | |
CN103860976B (zh) | 一种治疗婴幼儿皮炎的药物组合物 | |
CN109908247A (zh) | 一种治疗男性更年期综合症的中药药方 | |
CN105709060A (zh) | 一种中药制剂在制备治疗病毒性心肌炎的药物中的用途 | |
CN100408071C (zh) | 一种用鼻闻方法防治脱发症的中药及其制作方法 | |
CN105362784A (zh) | 一种治疗子宫肌瘤的中药组合物及其制备方法 | |
CN104771601A (zh) | 一种改善血粘度和血小板的聚集的组合剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181214 |